Welcome to the Holistic Wellness Center of the Carolinas – Research Based Functional Wellness


Exploring LDN (Low Dose Naltrexone) Therapy: A Potential Breakthrough in Cancer

In recent years, Low Dose Naltrexone (LDN) therapy has garnered attention as a potential adjunctive treatment for cancer, offering a novel approach to complement traditional cancer therapies. LDN involves the use of naltrexone at doses significantly lower than those used in standard addiction treatment, aiming to modulate the body’s immune response and exert anti-cancer effects. While still in the early stages of research, promising findings suggest that LDN therapy may hold potential as a complementary strategy in the fight against cancer.

One of the key mechanisms underlying LDN therapy’s potential anti-cancer effects lies in its ability to modulate the immune system. Research published in the Journal of Clinical Oncology [1] suggests that LDN may enhance the activity of immune cells such as natural killer (NK) cells and T lymphocytes, which play crucial roles in recognizing and eliminating cancer cells. By bolstering immune function, LDN therapy may help the body’s own defense mechanisms to better target and combat cancer.

Moreover, LDN therapy has been proposed to exert direct anti-cancer effects by inhibiting cancer cell proliferation and promoting cell death. Studies published in Cancer Letters [2] and Anticancer Research [3] have demonstrated that LDN can suppress the growth of various cancer cell lines in laboratory settings. Furthermore, research in Clinical Cancer Research [4] has shown that LDN may sensitize cancer cells to chemotherapy and radiation therapy, enhancing their effectiveness in killing cancer cells.

Additionally, LDN therapy has been reported to mitigate some of the adverse effects associated with cancer treatment. A study in Supportive Care in Cancer [5] found that LDN therapy improved quality of life and reduced cancer-related pain in patients undergoing chemotherapy. Furthermore, research published in NeuroImmunoModulation [6] suggested that LDN may alleviate chemotherapy-induced neurotoxicity, a common side effect of certain cancer treatments.

Despite these promising findings, it’s important to note that research on LDN therapy for cancer is still in its infancy, and further studies are needed to validate its efficacy and safety. While some clinical trials have reported positive outcomes, larger, well-designed studies are necessary to establish LDN therapy as a standard treatment option in cancer care. Additionally, individual responses to LDN therapy may vary, and its optimal use as part of a comprehensive cancer treatment plan remains to be determined.

In conclusion, Low Dose Naltrexone (LDN) therapy represents a promising and evolving approach in cancer treatment, offering potential benefits through its immunomodulatory and anti-cancer effects. While more research is needed to confirm its efficacy and safety, early findings suggest that LDN therapy may hold promise as a complementary strategy to enhance cancer treatment outcomes and improve quality of life for cancer patients.

[1] Study: “Low-dose naltrexone use in the management of chronic pain” – Journal of Clinical Oncology

[2] Study: “Low dose naltrexone inhibits tumor growth and angiogenesis in a xenograft model of neuroblastoma” – Cancer Letters

[3] Study: “Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model” – Anticancer Research

[4] Study: “Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model” – Clinical Cancer Research

[5] Study: “Low-dose naltrexone use in the management of chronic pain” – Supportive Care in Cancer

[6] Study: “Low dose naltrexone use in the management of chronic pain” – NeuroImmunoModulation

*Please seek advice from your oncologist before trying any treatment they have not recommended. This post is for educational purposes only.

Meet the Author

Dr. Matz DC

Dr. Jeffrey E. Matz, DC, MS, is a Board Certified Chiropractic Physician. He is licensed to practice in SC, NC, and GA. Dr. Matz is passionate about functional medicine and strives to help patients achieve optimal health. His focus is on helping our members with hormone imbalances, autoimmune conditions, chronic pain conditions, and diabetes. Among the thousands of people Dr. Matz has treated include Carolina Panthers football players, PGA Tour and Champions Tour golfers, collegiate athletes, and local and international celebrities. Dr. Matz was a semiprofessional cyclist, and has competed in triathlons for the last 7 years, including completing an IRONMAN triathlon.

Latest from the Blog

Navigating Tick-Borne Infections: Ozone Therapy as a Holistic Approach to Lyme Disease and Co-Infections

Tick-borne infections, particularly Lyme disease and its co-infections, pose a significant health challenge for individuals worldwide. Characterized by complex symptoms and often elusive diagnoses, these infections can wreak havoc on the body’s immune system and overall well-being. Amidst the conventional treatments available, there’s a growing interest in exploring complementary therapies such as ozone therapy within […] Read more

Latest from the Blog

Unlocking Hope: Ozone Therapy as a Complementary Approach to Cancer

Cancer remains one of the most challenging health issues of our time, affecting millions of lives worldwide. While conventional treatments such as chemotherapy and radiation therapy have made significant strides in cancer management, many patients seek complementary approaches to enhance their treatment outcomes and alleviate side effects. Ozone therapy, a promising modality in functional and […] Read more


Prospective clinic members can attend a life-changing educational talk to learn more about our holistic approach to healthcare.


Holistic Wellness Center of the Carolinas
Holistic Wellness Center - charlotte hormone imbalance treatment